Fenfluramine in the treatment of hypertensive patients with refractory obesity.
作者信息
Scott M E, Nelson P G
出版信息
Ulster Med J. 1975;44(1):56-61.
Abstract
摘要
相似文献
1
Fenfluramine in the treatment of hypertensive patients with refractory obesity.芬氟拉明治疗难治性肥胖高血压患者。
Ulster Med J. 1975;44(1):56-61.
2
Circulatory effects of fenfluramine in obese hypertensive patients.
Curr Ther Res Clin Exp. 1974 Nov;16(11):1197-202.
3
Hypotensive effect of fenfluramine in the treatment of obesity.
Practitioner. 1971 Jul;207(237):101-5.
4
A comparative trial of fenfluramine and diethylpropion in obese, hypertensive patients.氟苯丙胺与二乙丙胺苯丙酮治疗肥胖高血压患者的对照试验。
Br J Clin Pract. 1971 May;25(5):236-8.
5
Double-blind cross-over study of fenfluramine (Ponderax) in obesity.芬氟拉明（Ponderax）治疗肥胖症的双盲交叉研究。
J Assoc Physicians India. 1972 Nov;20(11):849-52.
6
[The effect of Ponderal in patients with refractory overweight].
Tidsskr Nor Laegeforen. 1973 Dec 30;93(35):2541-5.
7
[Treatment of obesity with fenfluramine (Ponderal)].用芬氟拉明（苯氟雷司）治疗肥胖症
Ugeskr Laeger. 1973 Sep 3;135(36):1932-7.
8
Fenfluramine-associated hypertension.芬氟拉明相关的高血压
West Afr J Pharmacol Drug Res. 1975 Dec;2(2):145-52.
9
[Treatment of obesity with fenfluramine (Ponderal) in general practice].
Ugeskr Laeger. 1979 Sep 24;141(39):2660-2.
10
Prolonged-action fenfluramine in non-diabetic patients with refractory obesity.长效芬氟拉明用于治疗难治性肥胖的非糖尿病患者。
Postgrad Med J. 1975;51 Suppl 1:155-7.
本文引用的文献
1
PREVALENCE OF CHRONIC DISEASES AND DISTRIBUTION OF SELECTED PHYSIOLOGIC VARIABLES IN A TOTAL COMMUNITY, TECUMSEH, MICHIGAN.密歇根州蒂康西一个完整社区的慢性病患病率及选定生理变量分布情况
Am J Epidemiol. 1965 May;81:307-22. doi: 10.1093/oxfordjournals.aje.a120517.
2
Antagonism of guanethidine and bretylium by various agents.多种药物对胍乙啶和溴苄铵的拮抗作用。
Lancet. 1962 Dec 15;2(7268):1282-3. doi: 10.1016/s0140-6736(62)92864-7.
3
Effect of weight loss on blood pressure.体重减轻对血压的影响。
J Am Diet Assoc. 1958 Dec;34(12):1309-12.
4
The effect of weight reduction upon the blood-pressure of obese hypertensive women.
Q J Med. 1954 Jul;23(91):331-45.
5
Relation of body weight to development of coronary heart disease. The Framingham study.体重与冠心病发病的关系。弗雷明汉姆研究。
Circulation. 1967 Apr;35(4):734-44. doi: 10.1161/01.cir.35.4.734.
6
Current therapeutics. CCXLI. The present status of anorexiant drugs.当前疗法。第411期。食欲抑制剂药物的现状。
Practitioner. 1968 Jan;200(195):167-73.
7
A clinical trial of fenfluramine.
Practitioner. 1965 Nov;195(169):677-80.
8
Drugs of dependence though not of abuse: fenfluramine and imipramine.虽非滥用但具依赖性的药物：芬氟拉明和丙咪嗪。
Br Med J. 1971 Jul 10;3(5766):70-3. doi: 10.1136/bmj.3.5766.70.
9
Depression following fenfluramine withdrawal.
Br J Psychiatry. 1972 Sep;121(562):338-9. doi: 10.1192/bjp.121.3.338-a.
10
A comparative trial of fenfluramine and diethylpropion in obese, hypertensive patients.氟苯丙胺与二乙丙胺苯丙酮治疗肥胖高血压患者的对照试验。
Br J Clin Pract. 1971 May;25(5):236-8.
Zotero 插件